MORC3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.268000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.969780E-01
Normal-vs-Stage2
6.954400E-02
Normal-vs-Stage3
5.174300E-02
Normal-vs-Stage4
3.401600E-01
Stage1-vs-Stage2
8.998000E-01
Stage1-vs-Stage3
1.292230E-01
Stage1-vs-Stage4
8.328400E-01
Stage2-vs-Stage3
1.398600E-01
Stage2-vs-Stage4
7.296400E-01
Stage3-vs-Stage4
1.305780E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.401600E-02
Normal-vs-AfricanAmerican
5.524200E-01
Normal-vs-Asian
1.188600E-01
Caucasian-vs-AfricanAmerican
1.432970E-01
Caucasian-vs-Asian
6.650800E-01
AfricanAmerican-vs-Asian
2.362200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.002000E-02
Normal-vs-Female
4.619600E-02
Male-vs-Female
9.889600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.002000E-01
Normal-vs-Age(41-60Yrs)
1.757570E-01
Normal-vs-Age(61-80Yrs)
3.144300E-02
Normal-vs-Age(81-100Yrs)
4.568000E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.832600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.408000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.335800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.924300E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.101850E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.066000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.516200E-02
Normal-vs-Daily Drinker
2.022100E-02
Normal-vs-Weekly Drinker
4.722500E-02
Normal-vs-Occasional Drinker
1.655770E-01
Normal-vs-Social Drinker
1.731370E-01
Non Drinker-vs-Daily Drinker
1.639620E-01
Non Drinker-vs-Weekly Drinker
5.653400E-01
Non Drinker-vs-Occasional Drinker
3.124000E-01
Non Drinker-vs-Social Drinker
7.127600E-01
Daily Drinker-vs-Weekly Drinker
5.497200E-01
Daily Drinker-vs-Occasional Drinker
4.656100E-02
Daily Drinker-vs-Social Drinker
1.879040E-01
Weekly Drinker-vs-Occasional Drinker
2.040000E-01
Weekly Drinker-vs-Social Drinker
4.845000E-01
Occasional Drinker-vs-Social Drinker
6.689600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.678400E-02
Normal-vs-Grade 2
3.384300E-03
Normal-vs-Grade 3
3.943500E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.840200E-02
Grade 1-vs-Grade 3
5.193700E-02
Grade 1-vs-Grade 4
7.678400E-02
Grade 2-vs-Grade 3
9.493200E-01
Grade 2-vs-Grade 4
3.384300E-03
Grade 3-vs-Grade 4
3.943500E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.489600E-02
Normal-vs-NonDiabetic
2.979600E-02
Diabetic-vs-NonDiabetic
8.742600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.030200E-02
Normal-vs-NoPancreatitis
3.588100E-02
Pancreatitis-vs-NoPancreatitis
9.168400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.498300E-02
Normal-vs-N1
5.889900E-02
N0-vs-N1
5.546400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.141180E-01
Normal-vs-TP53-NonMutant
1.248630E-01
TP53-Mutant-vs-TP53-NonMutant
7.555800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
